Martek Fiscal 2002 Sales Jump 144.7%; WIC Acceptance Aids Growth
This article was originally published in The Tan Sheet
Executive Summary
Infant formulas fortified with Martek Biosciences' DHA and ARA fatty acids have been accepted by the WIC program in roughly 15 states, Chief Executive Officer Henry Linsert said in a Dec. 12 analysts call
You may also be interested in...
Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
Martek Revenue Could Double, Reach $90 Mil. In FY 2003, CEO Says
Martek Biosciences expects to double its penetration in both domestic and international infant formula markets by next year, company execs said during a June 6 analysts' call
Mead DHA/ARA-Fortified Infant Formula Slated For February Release
Mead Johnson Nutritionals' Enfamil LIPIL, an infant formula fortified with ARA and DHA fatty acid oils, will be priced in the U.S. at a 10%-15% premium to the line's Enfamil with Iron product, the firm said